Corecivic shares owned by Cambridge Investment Research Advisors
Quarter-by-quarter ownership of Corecivic (CXW) shares owned by Cambridge Investment Research Advisors
from 13F filings
Historical chart of Cambridge Investment Research Advisors investment in Corecivic
Tip: Access up to 7 years of quarterly data
All positions including Corecivic held by Cambridge Investment Research Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csvQuarterly reported holdings in Corecivic by Cambridge Investment Research Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $462k | 23k | 20.35 |
| 2025-06-30 | $476k | 23k | 21.05 |
| 2025-03-31 | $495k | 24k | 20.30 |
| 2024-12-31 | $527k | 24k | 21.74 |
| 2024-09-30 | $349k | 28k | 12.64 |
| 2024-06-30 | $357k | 28k | 13.00 |
| 2024-03-31 | $516k | 33k | 15.61 |
| 2023-12-31 | $594k | 41k | 14.54 |
| 2023-09-30 | $459k | 41k | 11.25 |
| 2023-06-30 | $384k | 41k | 9.42 |
| 2023-03-31 | $413k | 45k | 9.19 |
| 2022-12-31 | $509k | 44k | 11.56 |
| 2022-09-30 | $408k | 46k | 8.85 |
| 2022-06-30 | $466k | 42k | 11.10 |
| 2022-03-31 | $475k | 43k | 11.17 |
| 2021-12-31 | $171k | 17k | 10.00 |
| 2021-09-30 | $159k | 18k | 8.89 |
| 2021-06-30 | $193k | 18k | 10.47 |
| 2021-03-31 | $160k | 18k | 9.07 |
| 2020-12-31 | $116k | 18k | 6.52 |
| 2020-09-30 | $1.2M | 152k | 8.00 |
| 2020-06-30 | $1.5M | 156k | 9.36 |
| 2020-03-31 | $1.7M | 153k | 11.17 |
| 2019-12-31 | $2.7M | 153k | 17.38 |
| 2019-09-30 | $1.4M | 70k | 20.76 |
| 2019-06-30 | $1.4M | 70k | 20.76 |
| 2019-03-31 | $1.3M | 69k | 19.44 |
| 2018-12-31 | $1.8M | 102k | 17.83 |
| 2018-09-30 | $2.4M | 99k | 24.33 |
| 2018-06-30 | $1.6M | 69k | 23.89 |
| 2018-03-31 | $1.3M | 67k | 19.51 |
| 2017-12-31 | $1.5M | 66k | 22.51 |
| 2017-09-30 | $1.6M | 60k | 26.77 |
| 2017-06-30 | $1.5M | 56k | 27.59 |
| 2017-03-31 | $1.7M | 54k | 31.42 |
| 2016-12-31 | $2.7M | 111k | 24.46 |
More positions owned by Cambridge Investment Research Advisors
View all positions for Cambridge Investment Research Advisors